Acrivon Therapeutics, Inc. Common Stock

Acrivon Therapeutics, Inc. Common Stock

ACRV
Acrivon Therapeutics, Inc. Common StockUS flagNASDAQ Global Market
1.73
USD
-0.02
- -
54.43MMarket Cap

Income Statement (USD)

APIChatGPT
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
As of date
12/31/2020
12/31/2021
12/31/2022
12/31/2023
12/31/2024
12/31/2025
Sales/Revenue/Turnover
- -
- -
- -
- -
- -
- -
+ Sales & Services Revenue
- -
- -
- -
- -
- -
- -
- Cost of Revenue
- -
- -
- -
- -
- -
- -
+ Cost of Goods & Services
- -
- -
- -
- -
- -
- -
Gross Profit
- -
- -
- -
- -
- -
- -
+ Other Operating Income
- -
- -
- -
- -
- -
- -
- Operating Expenses
3
16
33
67
89
84
+ Selling, General & Admin
1
2
9
21
25
24
+ Research & Development
2
14
24
46
64
60
+ Other Operating Expense
- -
- -
- -
- -
- -
- -
Operating Income (Loss)
-3
-16
-33
-67
-89
-84
- Non-Operating (Income) Loss
2
- -
-1
-7
-9
-6
+ Interest Expense, Net
- -
- -
- -
-7
-9
-6
+ Interest Expense
- -
- -
- -
- -
- -
- -
- Interest Income
- -
- -
- -
7
9
6
+ Other Non-Op (Income) Loss
2
- -
-1
- -
1
- -
Pretax Income
-5
-16
-31
-60
-81
-78
- Income Tax Expense (Benefit)
- -
- -
- -
- -
- -
- -
- (Income) Loss from Affiliates
- -
- -
- -
- -
- -
- -
Income (Loss) from Cont Ops
-5
-16
-31
-60
-81
-78
- Net Extraordinary Losses (Gains)
- -
- -
- -
- -
- -
- -
+ Discontinued Operations
- -
- -
- -
- -
- -
- -
+ Extraord. & Accounting Changes
- -
- -
- -
- -
- -
- -
Income (Loss) Incl. MI
-5
-16
-31
-60
-81
-78
- Minority Interest
- -
- -
- -
- -
- -
- -
Net Income, GAAP
-5
-16
-31
-60
-81
-78
- Preferred Dividends
- -
- -
- -
- -
- -
- -
- Other Adjustments
- -
- -
- -
- -
- -
- -
Net Income Avail to Common, GAAP
-5
-16
-31
-60
-81
-78
EBIT
-3
-16
-33
-67
-89
-84
EBITDA
-3
-16
-32
-67
-88
-83
EBITDA Margin (%)
- -
- -
- -
- -
- -
- -
EBITA
-3
-16
-33
-67
-89
-84
Gross Margin (%)
- -
- -
- -
- -
- -
- -
Operating Margin (%)
- -
- -
- -
- -
- -
- -
Profit Margin (%)
- -
- -
- -
- -
- -
- -
Sales per Employee
- -
- -
- -
- -
- -
- -
Dividend per Share
- -
- -
- -
- -
- -
- -
Depreciation Expense
- -
- -
- -
1
1
1
Basic Weighted Avg Shares
13
13
4
22
34
39
Basic EPS, GAAP
-0.41
-1.26
-7.56
-2.74
-2.38
-2.02
Basic EPS from Cont Ops
-0.41
-1.26
-7.56
-2.74
-2.38
-2.02
Diluted Weighted Avg Shares
13
13
4
22
34
39
Diluted EPS, GAAP
-0.41
-1.26
-7.56
-2.74
-2.38
-2.02
Diluted EPS from Cont Ops
-0.41
-1.26
-7.56
-2.74
-2.38
-2.02

Balance Sheet (USD)

APIChatGPT
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
As of date
12/31/2020
12/31/2021
12/31/2022
12/31/2023
12/31/2024
12/31/2025
Total Current Assets
2
100
132
130
182
120
+ Cash, Cash Equivalents & STI
2
100
128
127
179
119
+ Cash & Cash Equivalents
2
100
30
36
40
41
+ ST Investments
- -
- -
98
91
140
77
+ Accounts & Notes Receiv
- -
- -
- -
- -
- -
- -
+ Accounts Receivable, Net
- -
- -
- -
- -
- -
- -
+ Notes Receivable, Net
- -
- -
- -
- -
- -
- -
+ Loans Receivable, Net
- -
- -
- -
- -
- -
- -
+ Other Receivable, Net
- -
- -
- -
- -
- -
- -
+ Inventories
- -
- -
- -
- -
- -
- -
+ Raw Materials
- -
- -
- -
- -
- -
- -
+ Work In Process
- -
- -
- -
- -
- -
- -
+ Finished Goods
- -
- -
- -
- -
- -
- -
+ Inventory Adjustments
- -
- -
- -
- -
- -
- -
+ Other Inventory
- -
- -
- -
- -
- -
- -
+ Other ST Assets
- -
1
4
2
2
2
+ Misc ST Assets
- -
- -
- -
- -
- -
- -
+ Prepaid Expenses
- -
- -
- -
- -
- -
- -
+ ST Derivative & Hedging Assets
- -
- -
- -
- -
- -
- -
+ ST Assets Held-for-Sale
- -
- -
- -
- -
- -
- -
+ ST Deferred Tax Assets
- -
- -
- -
- -
- -
- -
Total Noncurrent Assets
- -
6
49
9
15
9
+ Property, Plant & Equip, Net
- -
6
7
8
8
7
+ Property, Plant & Equip
- -
6
7
9
10
11
- Accumulated Depreciation
- -
- -
- -
1
2
3
+ LT Investments & Receivables
- -
- -
42
- -
5
- -
+ LT Investments
- -
- -
42
- -
5
- -
+ LT Receivables
- -
- -
- -
- -
- -
- -
+ Other LT Assets
- -
- -
- -
1
2
2
+ Total Intangible Assets
- -
- -
- -
- -
- -
- -
+ Goodwill
- -
- -
- -
- -
- -
- -
+ Other Intangible Assets
- -
- -
- -
- -
- -
- -
+ LT Deferred Tax Assets
- -
- -
- -
- -
- -
- -
+ LT Derivative & Hedging Assets
- -
- -
- -
- -
- -
- -
+ Misc LT Assets
- -
- -
- -
1
2
2
Total Assets
2
107
181
138
197
130
+ Payables & Accruals
- -
2
3
9
11
9
+ Accounts Payable
- -
1
1
5
1
2
+ Accrued Taxes
- -
- -
- -
- -
- -
- -
+ Interest & Dividends Payable
- -
- -
- -
- -
- -
- -
+ Other Payables & Accruals
- -
1
2
4
10
7
+ ST Debt
- -
1
1
1
1
1
+ ST Borrowings
- -
- -
- -
- -
- -
- -
+ ST Finance Leases
- -
1
1
1
1
1
+ Other ST Liabilities
- -
1
3
4
5
6
+ Deferred Revenue
- -
- -
- -
- -
- -
- -
+ Derivatives & Hedging
- -
- -
- -
- -
- -
- -
+ Deferred Tax Liabilities
- -
- -
- -
- -
- -
- -
+ Misc ST Liabilities
- -
1
3
4
5
6
Total Current Liabilities
1
3
7
13
17
16
+ LT Debt
- -
5
4
4
3
2
+ LT Borrowings
- -
- -
- -
- -
- -
- -
+ LT Finance Leases
- -
5
4
4
3
2
+ Other LT Liabilities
10
123
- -
- -
- -
- -
+ Accrued Liabilities
- -
- -
- -
- -
- -
- -
+ Pension Liabilities
- -
- -
- -
- -
- -
- -
+ Deferred Revenue
- -
- -
- -
- -
- -
- -
+ Deferred Tax Liabilities
- -
- -
- -
- -
- -
- -
+ Derivatives & Hedging
- -
- -
- -
- -
- -
- -
+ Misc LT Liabilities
10
123
- -
- -
- -
- -
Total Noncurrent Liabilities
10
127
4
4
3
2
Total Liabilities
11
130
11
17
20
17
+ Preferred Equity and Hybrid Capital
- -
- -
- -
- -
- -
- -
+ Share Capital & APIC
- -
1
227
238
373
387
+ Common Stock
- -
- -
- -
- -
- -
- -
+ Additional Paid in Capital
- -
1
227
238
373
387
- Treasury Stock
- -
- -
- -
- -
- -
- -
+ Retained Earnings
-9
-25
-56
-116
-197
-275
+ Other Equity
- -
- -
- -
- -
- -
- -
Equity Before Minority Interest
-8
-24
170
121
177
113
+ Minority/Non Controlling Interest
- -
- -
- -
- -
- -
- -
Total Equity
-8
-24
170
121
177
113
Total Liabilities & Equity
2
107
181
138
197
130
Shares Outstanding
19
19
22
23
31
32
Number of Employees
- -
- -
- -
- -
- -
- -
Capital Leases - Total
- -
6
5
5
4
3
Net Debt
-2
-100
-30
-36
-40
-41
Net Debt to Equity
18.13
418.34
-17.32
-29.72
-22.52
-36.88
Tangible Common Equity Ratio
-385.03
-22.34
94.07
87.65
89.93
86.74
Current Ratio
2.8
34.46
20.27
9.75
10.55
7.69
Cash Conversion Cycle
- -
- -
- -
- -
- -
- -

Cash Flow Statement (USD)

APIChatGPT
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
As of date
12/31/2020
12/31/2021
12/31/2022
12/31/2023
12/31/2024
12/31/2025
+ Net Income
-5
-16
-31
-60
-81
-78
+ Depreciation & Amortization
- -
- -
- -
1
1
1
+ Non-Cash Items
2
2
2
9
11
15
+ Stock-Based Compensation
- -
- -
2
12
14
15
+ Deferred Income Taxes
- -
- -
- -
- -
- -
- -
+ Asset Impairment Charge
- -
- -
- -
- -
- -
- -
+ Other Non-Cash Adj
2
1
- -
-3
-3
1
+ Chg in Non-Cash Work Cap
- -
- -
-2
8
2
-2
+ (Inc) Dec in Accts Receiv
- -
- -
- -
- -
- -
- -
+ (Inc) Dec in Inventories
- -
- -
- -
- -
- -
- -
+ (Inc) Dec in Prepaid Assets
- -
-1
-4
2
- -
- -
+ Inc (Dec) in Accts Payable
- -
2
3
7
4
-2
+ Inc (Dec) in Other
- -
-1
-1
-1
-2
-1
+ Net Cash From Disc Ops
- -
- -
- -
- -
- -
- -
Cash from Operating Activities
-3
-14
-30
-43
-66
-64
+ Change in Fixed & Intang
- -
- -
- -
- -
- -
- -
+ Disp in Fixed & Intang
- -
- -
- -
- -
- -
- -
+ Disp of Fixed Prod Assets
- -
- -
- -
- -
- -
- -
+ Disp of Intangible Assets
- -
- -
- -
- -
- -
- -
+ Acq of Fixed & Intang
- -
- -
-2
-1
-3
-2
+ Acq of Fixed Prod Assets
- -
- -
-2
-1
-3
-2
+ Acq of Intangible Assets
- -
- -
- -
- -
- -
- -
+ Cash (Repurchase) of Equity
- -
- -
104
- -
70
- -
+ Increase in Capital Stock
- -
- -
104
- -
70
- -
+ Decrease in Capital Stock
- -
- -
- -
- -
- -
- -
+ Net Change in LT Investment
- -
- -
-140
52
-49
68
+ Dec in LT Investment
- -
- -
11
109
154
150
+ Inc in LT Investment
- -
- -
-150
-57
-203
-82
+ Net Cash From Acq & Div
- -
- -
- -
- -
- -
- -
+ Cash from Divestitures
- -
- -
- -
- -
- -
- -
+ Cash for Acq of Subs
- -
- -
- -
- -
- -
- -
+ Cash for JVs
- -
- -
- -
- -
- -
- -
+ Other Investing Activities
- -
- -
- -
- -
- -
- -
+ Net Cash From Disc Ops
- -
- -
- -
- -
- -
- -
Cash from Investing Activities
- -
- -
-142
51
-52
66
+ Dividends Paid
- -
- -
- -
- -
- -
- -
+ Net Cash From Debt
- -
- -
- -
- -
- -
- -
+ Cash From Debt
- -
- -
- -
- -
- -
- -
+ Repayments of Debt
- -
- -
- -
- -
- -
- -
+ Other Financing Activities
3
112
-3
-2
51
-1
+ Net Cash From Disc Ops
- -
- -
- -
- -
- -
- -
Cash from Financing Activities
3
112
102
-2
121
-1
Effect of Foreign Exchange Rates
- -
- -
- -
- -
- -
- -
Net Changes in Cash
- -
98
-70
7
4
2
EBITDA
-3
-16
-32
-67
-88
-83
EBITDA Margin (%)
- -
- -
- -
- -
- -
- -
Free Cash Flow
-3
-14
-32
-44
-68
-65
Net Cash Paid for Acquisitions
- -
- -
- -
- -
- -
- -
Free Cash Flow to Firm
- -
- -
- -
- -
- -
- -
Free Cash Flow to Equity
- -
-14
-32
-44
-68
-65
Free Cash Flow per Basic Share
-0.22
-1.1
-7.83
-1.99
-2.03
-1.7
Price/Free Cash Flow
- -
- -
-1.7
-2.63
-3.23
-1.5
Cash Flow to Net Income
0.53
0.86
0.97
0.71
0.82
0.82
Capital Expenditures
- -
- -
-2
-1
-3
-2